PPM1D and acute myeloid leukemia: The authors’ data indicate that PPM1D is a crucial regulator of HSC fitness and that its absence or pharmacological inhibition leads to greater sensitivity of malignant cells to chemotherapy, including in acute myeloid leukemia (AML) xenografts.